Site intended for healthcare professionals only
To date, there are no effective antiviral medications for COVID-19. Drug repurposing, a strategy that uses existing drugs, offers potential prevention and treatment options for COVID-19. We discuss one treatment […]
» Read moreSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was declared a pandemic on 11 March 2020. We have since seen its fast spread worldwide. A likely contributing factor was the […]
» Read moreBackground SARS-CoV-2 and its associated disease, COVID-19, has infected over seven million people world-wide, including two million people in the United States. While many people recover from the virus uneventfully, […]
» Read moreHydroxychloroquine (HCQ) has been promoted as a potential treatment for COVID-19 but there are safety concerns.To determine the effect of HCQ treatment on QT interval METHODS: We retrospectively studied the […]
» Read moreUnderlying lung disease, especially asthma, has recently been found to be associated with a higher risk of hospitalization with coronavirus disease 2019 (COVID-19) infection. Inhaled corticosteroids (ICS) are the most […]
» Read moreBecause of in vitro studies, hydroxychloroquine is under evaluation as a preexposure or postexposure prophylaxis for coronavirus disease (COVID-19) and as a possible COVID-19 curative treatment. We report a case […]
» Read moreIn view of the COVID-19 pandemic and the predicted risk of severe infection in immunocompromised patients, chemotherapy protocols for patients with Acute Myeloid Leukaemia (AML) have been modified in some […]
» Read moreWe briefly frame challenges and steps to overcoming those challenges in delivering care for patients with bipolar disorder via telehealth or telephone during COVID-19. Telehealth provides an invaluable opportunity to […]
» Read moreThe World Health Organization (WHO) has declared the outbreak of 2019 novel coronavirus, known as 2019-nCoV, a pandemic, as the coronavirus has now infected over 2.6 million people globally and […]
» Read more[This corrects the article DOI: 10.1021/acscentsci.0c00489.]. Click here to read the full article @ ACS central science
» Read moreThe majority of available US-published reports present populations with community spread in urban areas. The objective of this report is to describe a rural healthcare system’s utilisation of therapeutic options […]
» Read moreItaly has been badly affected by COVID-19, despite strict quarantine measures. Up to 1 June 2020, 2.1% of the positive cases in Italy were aged 0-18 years, with no paediatric […]
» Read moreCOVID-19 pandemic is affecting various areas of health care, including human reproduction. Many women with reproductive failures, during the peri-implantation period and pregnancy, are on the immunotherapy using immune modulators […]
» Read morePatients with COVID-19 are sometimes already being treated for one or more other chronic conditions, especially if they are elderly. Introducing a treatment against COVID-19, either on an outpatient basis […]
» Read moreLike severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of […]
» Read moreThe clinical therapy for severe 2019 coronavirus disease (i.e., COVID-19) sufferers is relatively challenging. Herein, the processes involving salvage of a critical COVID-19 patient were retrospectively analyzed. The condition of […]
» Read moreThe impact of the COVID-19 pandemic is far reaching, with devastating effects on individuals, communities, and societies across the world. People with chronic health conditions may be at greater risk […]
» Read moreCoronavirus disease 2019 (COVID-19) is now a global public threat. Given the pandemic of COVID-19, the economic impact of COVID-19 is essential to add value to the policy-making process. We […]
» Read moreThe latest study observed that KTRs with COVID-19 had a higher early mortality than persons with COVID-19 in the general population[1] . To date, there is no specific drugs. Previous […]
» Read moreCOVID-19 challenges and needs required health systems to rapidly redesign the delivery of care.To describe our approach in using health information technology to provide a continuum of services during the […]
» Read moreAs a part of measures to decrease spikes in coronavirus disease (COVID-19) cases and deaths outside of hospitals, the government of South Korea introduced a plan for community treatment centers […]
» Read moreAs hospitals have experienced a surge of Covid-19 patients, investigators of Covid-19 treatment trials face a difficult problem: when an institution has more eligible and interested patients than trial slots, […]
» Read moreGlucocorticoids are widely used in the treatment of various pulmonary inflammatory diseases, but they are also often accompanied by significant adverse reactions. Published guidelines point out that low dose and […]
» Read moreThe novel coronavirus (severe acute respiratory syndrome coronavirus 2[SARS-CoV-2]) outbreak is now a pandemic, thousands of people now self-quarantined because of possible infection with the coronavirus, this situation makes telemedicine […]
» Read moreCoronavirus disease 2019 (SARS-CoV2) is an active global health threat for which treatments are desperately being sought. Even though most people infected experience mild to moderate respiratory symptoms and recover […]
» Read moreHemostatic abnormalities and thrombotic risk associated with coronavirus disease 2019 (COVID-19) are among the most discussed topics in the management of this disease. The aim of this position paper is […]
» Read moreMost persons with confirmed coronavirus disease (COVID-19) have no or mild symptoms. During the COVID-19 pandemic, communities need efficient methods to monitor asymptomatic patients to reduce transmission. We describe the […]
» Read moreWe evaluated the clinical course of asymptomatic and mildly symptomatic patients with laboratory-confirmed coronavirus disease (COVID-19) admitted to community treatment centers (CTCs) for isolation in South Korea. Of 632 patients, […]
» Read moreThe COVID-19 pandemic has caused disruptions in cancer care around the world due to logistical and psychosocial reasons. This paper was written with the primary objective of providing a guide […]
» Read moreCOVID-19 is an ongoing threat to society. Patients who develop the most severe forms of the disease have high mortality. The interleukin-6 inhibitor tocilizumab has the potential to improve outcomes […]
» Read more